Acute kidney injury
Also known as: AKI, Acute renal injury, Acute renal failure
Acute kidney injury (AKI) involves a rapid decline in renal function, clinically defined by an acute rise in serum creatinine or a reduction in urine output. Aetiological factors include prerenal hypoperfusion, intrinsic parenchymal damage, or postrenal obstruction, frequently occurring secondary to sepsis or neurological impairment. Suspected AKI constitutes a medical emergency requiring immediate tertiary assessment for haemodynamic stabilisation and management of the underlying pathology. Acupuncture and Chinese herbal medicine are contraindicated during the acute phase. TCM intervention is restricted to the management of residual sequelae only once the patient is medically stable and explicit clearance is obtained from the treating nephrologist. The cited evidence, comprising mechanistic reviews and an uncontrolled case report, does not establish the safety or efficacy of TCM for renal recovery.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere strictly to fluid intake volumes prescribed by the medical team; do not adjust intake independently.
- •Maintain a comprehensive record of all pharmacological agents and supplements; avoid non-steroidal anti-inflammatory drugs (NSAIDs) and new herbal products unless authorised by the renal specialist.
- •Follow precise dietary protocols as specified by the specialist; do not implement salt, protein, or potassium restrictions without professional medical guidance.
- •Monitor body weight, blood pressure, and urine output only as clinically directed, attend scheduled blood tests, and gradually resume physical activity following medical clearance.
Cautions & Contraindications
- •Suspected or ongoing AKI, sepsis, haemodynamic instability or acute neurological deterioration precludes elective TCM treatment: refer immediately. The supplied mechanistic reviews support the seriousness of multi-organ illness, not an acupuncture safety protocol.[,]
- •Do not use mechanistic herbal findings as evidence that a product is safe or effective after AKI. Residual renal impairment, pregnancy, polypharmacy, uncertain ingredients or lack of renal-team approval are reasons to withhold herbal prescribing pending specialist review.[]
- •Defer needling with active bleeding, clinically significant thrombocytopenia or coagulopathy, infected skin or unstable illness; review anticoagulation and immune compromise individually. These are practitioner safety precautions, not conclusions established by the supplied single case report.[]
- •Never use the uncontrolled multimodal case report to justify treatment against nephrology advice, withdrawal of prescribed medicines, delayed dialysis or delayed investigation of obstruction.[]
When to reassess or seek care again
Acute presentations require immediate medical assessment, not a trial of TCM. After complete medical stabilisation, record baseline fatigue and sleep scores (0–10), appetite and functional tolerance, and review any agreed supportive treatment within 1–2 weeks. Renal clinicians determine earlier creatinine, electrolyte, blood pressure and fluid-balance monitoring; arrange kidney recovery and CKD assessment at approximately 3 months or sooner as directed. Stop adjunctive treatment and obtain urgent medical review for falling urine output, increasing weight or oedema, worsening blood results, fever or new systemic symptoms. Lack of symptom improvement within 2–4 weeks warrants reconsideration rather than escalation of herbs. These practical intervals and safety triggers are not validated by the supplied abstracts. Sources 1–3 are mechanistic reviews; source 4 is one uncontrolled multimodal case report and cannot isolate acupuncture effects or distinguish treatment benefit from natural recovery and other care.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- Seminars in nephrology · 2026
- Clinical immunology (Orlando, Fla.) · 2026
- FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
- Medical acupuncture · 2026
- Cochrane Database of Systematic Reviews · 2015
Systematic review supporting PC6 stimulation for postoperative nausea and vomiting.
- JAMA Surgery · 2023
Randomised trial including ST36 for postoperative gastrointestinal recovery.
- Medical Journal of Australia · 2017
Australian emergency-department trial of acupuncture used alongside standard analgesic care.
- World Health Organization · 2008
Standard point locations used for the adjunctive points listed.
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
